Immune responses against the mutated region of cytoplasmatic NPM1 might contribute to the favorable clinical outcome of AML patients with NPM1 mutations (NPM1(mut))

Erstveröffentlichung
2013
Authors
Greiner, Jochen
Schneider, Vanessa
Schmitt, Michael
Goetz, Marlies
Doehner, Konstanze
et al.
Wissenschaftlicher Artikel


Published in
Blood ; 122 (2013), 6. - S. 1087-1088. - ISSN 0006-4971
Link to publication
https://dx.doi.org/10.1182/blood-2013-04-496844
Institutions
UKU. Klinik für Innere Medizin III
Institut für Klinische Transfusionsmedizin und Immungenetik Ulm gGmbH (IKT)
Subject headings
[Free subject headings]: acute myeloid-leukemia | t-cell responses | peptide vaccination | nucleophosmin
[DDC subject group]: DDC 610 / Medicine & health
Metadata
Show full item record